tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VTVT Stock Latest News

vTv Therapeutics Inc. (VTVT) Q4 Earnings Cheat Sheet
Pre-EarningsvTv Therapeutics Inc. (VTVT) Q4 Earnings Cheat Sheet
2d ago
VTVT
vTv Therapeutics Expands Global HPP737 Rights with Newsoara
PremiumCompany Announcements
vTv Therapeutics Expands Global HPP737 Rights with Newsoara
17d ago
8K
VTVT
vTv Therapeutics expanded its license agreement with Newsoara Biopharma
PremiumThe Fly
vTv Therapeutics expanded its license agreement with Newsoara Biopharma
17d ago
VTVT
vTv Therapeutics price target raised to $49 from $40 at BTIG
PremiumThe Fly
vTv Therapeutics price target raised to $49 from $40 at BTIG
23d ago
VTVT
vTv Therapeutics initiated with a Buy at Roth Capital
PremiumThe Fly
vTv Therapeutics initiated with a Buy at Roth Capital
28d ago
VTVT
vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
PremiumRatingsvTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
1M ago
VTVT
vTv Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
vTv Therapeutics initiated with a Buy at TD Cowen
2M ago
VTVT
Paradigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
Premium
Ratings
Paradigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
2M ago
VTVT
vTv Therapeutics price target raised to $47 from $36 at H.C. Wainwright
PremiumThe Fly
vTv Therapeutics price target raised to $47 from $36 at H.C. Wainwright
2M ago
VTVT
vTv submits cadisegliatin study protocol to Department of Health Abu Dhabi
PremiumThe Fly
vTv submits cadisegliatin study protocol to Department of Health Abu Dhabi
2M ago
VTVT
Positive Outlook for vTv Therapeutics: Buy Rating on Cadisegliatin’s Promising Phase 3 Trial and Market Potential
PremiumRatings
Positive Outlook for vTv Therapeutics: Buy Rating on Cadisegliatin’s Promising Phase 3 Trial and Market Potential
3M ago
VTVT
vTv Therapeutics initiated with a Buy at BTIG
PremiumThe Fly
vTv Therapeutics initiated with a Buy at BTIG
3M ago
VTVT
Promising Outlook for vTv Therapeutics: Buy Rating Affirmed Amidst Advancements in Type 1 Diabetes Treatment
PremiumRatingsPromising Outlook for vTv Therapeutics: Buy Rating Affirmed Amidst Advancements in Type 1 Diabetes Treatment
3M ago
VTVT
vTv Therapeutics reports Q3 EPS ($1.08), consensus (98c)
Premium
The Fly
vTv Therapeutics reports Q3 EPS ($1.08), consensus (98c)
3M ago
VTVT
vTv Therapeutics trading resumes
Premium
The Fly
vTv Therapeutics trading resumes
4M ago
VTVT
vTv Therapeutics trading halted, volatility trading pause
PremiumThe Fly
vTv Therapeutics trading halted, volatility trading pause
4M ago
VTVT
vTv Therapeutics’ Promising Phase 3 Study on Cadisegliatin for Type 1 Diabetes
PremiumCompany Announcements
vTv Therapeutics’ Promising Phase 3 Study on Cadisegliatin for Type 1 Diabetes
4M ago
VTVT
vTv Therapeutics announces three appointments to Scientific Advisory Board
PremiumThe Fly
vTv Therapeutics announces three appointments to Scientific Advisory Board
4M ago
VTVT
vTv Therapeutics files to sell 15.88M shares of Class A common stock for holders
PremiumThe Fly
vTv Therapeutics files to sell 15.88M shares of Class A common stock for holders
5M ago
VTVT
vTv Therapeutics trading resumes
PremiumThe FlyvTv Therapeutics trading resumes
5M ago
VTVT
vTv Therapeutics trading halted, volatility trading pause
Premium
The Fly
vTv Therapeutics trading halted, volatility trading pause
5M ago
VTVT
vTv Therapeutics to Join Morgan Stanley Conference
Premium
Company Announcements
vTv Therapeutics to Join Morgan Stanley Conference
5M ago
8K
VTVT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >